Skip to main content

Table 4 Hazard ratio and 95% confidence intervals for cardiovascular risk factors and specific VTE type in strata of blood ABO group for metabolic conditions

From: Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women

 

p-interaction*

All VTE

Pulmonary Embolism

Deep vein thrombosis

Primary

Secondary

Group O

hypertension

0.01

1.14 (0.95: 1.38)

1.21 (0.88: 1.68)

1.10 (0.88: 1.39)

1.56 (1.07: 2.27)

1.03 (0.83: 1.28)

dyslipidaemia

0.78

0.70 (0.58: 0.85)

1.10 (0.78: 1.53)

0.60 (0.44: 0.83)

0.67 (0.42: 1.09)

0.82 (0.64: 1.06)

diabetes

0.82

0.68 (0.36: 1.29)

0.55 (0.20: 1.50)

0.79 (0.35: 1.80)

1.31 (0.47: 3.66)

0.51 (0.23: 1.17)

Group non-O

hypertension

–

0.97 (0.85: 1.11)

1.05 (0.82: 1.36)

0.95 (0.81: 1.10)

0.78 (0.60: 1.01)

1.05 (0.90: 1.23)

dyslipidaemia

–

0.78 (0.69: 0.88)

0.78 (0.63: 0.97)

0.78 (0.67: 0.90)

0.63 (0.48: 0.83)

0.83 (0.72: 0.95)

diabetes

–

0.78 (0.51: 1.18)

1.19 (0.66: 2.15)

0.56 (0.31: 1.01)

1.02 (0.47: 2.19)

0.71 (0.43: 1.16)

  1. * interaction with all-VTE
  2. * adjusted on education level, statin use, menopause, MHT use, parity, type of menopause, family history of CVD and BMI